| Dr Christopher Bryan Hovland, MD | |
|
1901 Sw H K Dodgen Loop, Temple, TX 76502-1814 | |
| (254) 724-5437 | |
| Not Available |
| Full Name | Dr Christopher Bryan Hovland |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 1901 Sw H K Dodgen Loop, Temple, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124389093 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | PIT 566341 (Texas) | Secondary |
| 208000000X | Pediatrics | Q4132 (Texas) | Primary |
| Entity Name | Scott & White Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093779704 PECOS PAC ID: 8123923604 Enrollment ID: O20031223000640 |
News Archive
World Vision has signed an agreement with Air Serv International to provide one light aircraft to transport people and cargo (14,000 lbs capacity) between Santo Domingo and Port-au-Prince. The first flights began today, making two rotations per day. According to relief staff, these flights will radically improve transports of staff and goods.
Drugmaker Merck announced it is closing eight research centers and eight manufacturing plants and laying off 15,000 people from its worldwide operations during the next two years because of its merger with Schering-Plough. "The restructuring is expected to save $2.7 billion to $3.1 billion in 2012, the company said. Meanwhile, the pretax cost of the initial phase of the cost-cutting program is expected to range from $3.5 billion to $4.3 billion, much of it in severance packages for employees."
"Off label" drugs are medications that have not been tested for safety or efficacy for a specific patient age or condition. New research presented Oct. 21 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in New Orleans found that off-label treatments were ordered for 96 percent of all pediatric patients, and 100 percent of patients ages 13-17, in the intensive care unit of an urban children's hospital.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced that it has entered into a committed equity financing facility under which it may sell up to $20 million of its registered common stock to Commerce Court Small Cap Value Fund, Ltd. over an approximately 18-month period. Poniard is not obligated to utilize any of the facility and remains free to enter into other financing transactions.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher Bryan Hovland, MD Po Box 844658, Dallas, TX 75284-4658 Ph: (254) 724-8800 | Dr Christopher Bryan Hovland, MD 1901 Sw H K Dodgen Loop, Temple, TX 76502-1814 Ph: (254) 724-5437 |
News Archive
World Vision has signed an agreement with Air Serv International to provide one light aircraft to transport people and cargo (14,000 lbs capacity) between Santo Domingo and Port-au-Prince. The first flights began today, making two rotations per day. According to relief staff, these flights will radically improve transports of staff and goods.
Drugmaker Merck announced it is closing eight research centers and eight manufacturing plants and laying off 15,000 people from its worldwide operations during the next two years because of its merger with Schering-Plough. "The restructuring is expected to save $2.7 billion to $3.1 billion in 2012, the company said. Meanwhile, the pretax cost of the initial phase of the cost-cutting program is expected to range from $3.5 billion to $4.3 billion, much of it in severance packages for employees."
"Off label" drugs are medications that have not been tested for safety or efficacy for a specific patient age or condition. New research presented Oct. 21 at the American Academy of Pediatrics (AAP) National Conference and Exhibition in New Orleans found that off-label treatments were ordered for 96 percent of all pediatric patients, and 100 percent of patients ages 13-17, in the intensive care unit of an urban children's hospital.
Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, today announced that it has entered into a committed equity financing facility under which it may sell up to $20 million of its registered common stock to Commerce Court Small Cap Value Fund, Ltd. over an approximately 18-month period. Poniard is not obligated to utilize any of the facility and remains free to enter into other financing transactions.
› Verified 1 days ago
Dr. Ezhilarasi Manickavasagam, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 2112 Sw H K Dodgen Loop Ste 110, Temple, TX 76504 Phone: 877-800-5722 | |
Dr. Madhava Reddy Beeram, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1901 Sw H K Dodgen Loop, Temple, TX 76502 Phone: 254-935-4000 | |
Dr. Michael C. Smith, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Edwin Hernandez Caro, Pediatrics Medicare: Medicare Enrolled Practice Location: 1901 Sw H K Dodgen Loop Bldg 300, Temple, TX 76502 Phone: 254-724-5437 | |
Dr. Alisa Ana Acosta, MD, MPH Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Dr. Holly Mead Fatter, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-5092 | |
Parneet Dhaliwal, Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2401 South 31st Street, Ms-ck 300, Temple, TX 76508 Phone: 254-935-5063 |